Kyohei Haruta, Hiroshi Aoi, Kinuko Kimura, Kazuya Okada, C. Mikami, Masaki Murata, Sayo Matsuda, Kana Sado, I. Yoshikawa, Kazuyuki Ikeda
{"title":"注射用油基溶剂对CSTD的破坏与洗脱","authors":"Kyohei Haruta, Hiroshi Aoi, Kinuko Kimura, Kazuya Okada, C. Mikami, Masaki Murata, Sayo Matsuda, Kana Sado, I. Yoshikawa, Kazuyuki Ikeda","doi":"10.5649/jjphcs.47.590","DOIUrl":null,"url":null,"abstract":"Busulfex ® is a non-aqueous injection of insoluble Busulfan dissolved in the oil-based solvents Polyethylene Glycol 400 (PEG400) and N,N -Dimethylacetamide (DMA). The use of a closed system transfer device (CSTD) is strongly recom-mended for the preparation of all hazardous drugs, and we use a CSTD for the preparation and administration of anticancer drugs at Nara Medical University Hospital. We experienced a case of frequent blockage of the intravenous route when Busulfex ® was administered. In the present study, when the test solution containing PEG400 and DMA mixed in the same ratio as Busulfex ® was syringe aspirated by CSTD, the CSTD was broken and foreign particles were generated within 3 minutes of aspiration. When DMA was syringe aspirated by CSTD, polycarbonate, the material of CSTD, was eluted, and functional abnormality of CSTD was observed 30 minutes after aspiration. Oil-based solvents are used as additives in many anticancer drugs. The suitability of a CSTD for the preparation of anticancer drugs should be deter-mined by considering not only the hazard classification of the anticancer drug, but also the type and ratio of the additives.","PeriodicalId":14574,"journal":{"name":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","volume":"51 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Breakage and Elution of CSTD by Oil-based Solvents in Injection Drugs\",\"authors\":\"Kyohei Haruta, Hiroshi Aoi, Kinuko Kimura, Kazuya Okada, C. Mikami, Masaki Murata, Sayo Matsuda, Kana Sado, I. Yoshikawa, Kazuyuki Ikeda\",\"doi\":\"10.5649/jjphcs.47.590\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Busulfex ® is a non-aqueous injection of insoluble Busulfan dissolved in the oil-based solvents Polyethylene Glycol 400 (PEG400) and N,N -Dimethylacetamide (DMA). The use of a closed system transfer device (CSTD) is strongly recom-mended for the preparation of all hazardous drugs, and we use a CSTD for the preparation and administration of anticancer drugs at Nara Medical University Hospital. We experienced a case of frequent blockage of the intravenous route when Busulfex ® was administered. In the present study, when the test solution containing PEG400 and DMA mixed in the same ratio as Busulfex ® was syringe aspirated by CSTD, the CSTD was broken and foreign particles were generated within 3 minutes of aspiration. When DMA was syringe aspirated by CSTD, polycarbonate, the material of CSTD, was eluted, and functional abnormality of CSTD was observed 30 minutes after aspiration. Oil-based solvents are used as additives in many anticancer drugs. The suitability of a CSTD for the preparation of anticancer drugs should be deter-mined by considering not only the hazard classification of the anticancer drug, but also the type and ratio of the additives.\",\"PeriodicalId\":14574,\"journal\":{\"name\":\"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)\",\"volume\":\"51 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5649/jjphcs.47.590\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/jjphcs.47.590","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Breakage and Elution of CSTD by Oil-based Solvents in Injection Drugs
Busulfex ® is a non-aqueous injection of insoluble Busulfan dissolved in the oil-based solvents Polyethylene Glycol 400 (PEG400) and N,N -Dimethylacetamide (DMA). The use of a closed system transfer device (CSTD) is strongly recom-mended for the preparation of all hazardous drugs, and we use a CSTD for the preparation and administration of anticancer drugs at Nara Medical University Hospital. We experienced a case of frequent blockage of the intravenous route when Busulfex ® was administered. In the present study, when the test solution containing PEG400 and DMA mixed in the same ratio as Busulfex ® was syringe aspirated by CSTD, the CSTD was broken and foreign particles were generated within 3 minutes of aspiration. When DMA was syringe aspirated by CSTD, polycarbonate, the material of CSTD, was eluted, and functional abnormality of CSTD was observed 30 minutes after aspiration. Oil-based solvents are used as additives in many anticancer drugs. The suitability of a CSTD for the preparation of anticancer drugs should be deter-mined by considering not only the hazard classification of the anticancer drug, but also the type and ratio of the additives.